New: NCI-funded clinical trial search
Mednet Logo

Would you consider using capecitabine in a patient who previously had encephalopathy with 5-FU?

2 Answers
Mednet Member
Medical Oncology · Los Angeles VA Medical Center
Answered on

I will offer my anecdote of a patient I've treated with metastatic rectal cancer. When given FOLFIRI/bev, he felt terrible 1-2 days after the 5-FU pump started. 1st cycle, bounced back with time. 2nd cycle, went to the ER and got admitted for encephalopathy, had hyperammonemia and lactic acidosis. Several case reports such as this one have noted this rare side effect of 5-FU treatment related to changes in the TCA cycle and urea cycle for the lactic acidosis and hyperammonemia, respectively.

I l...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Medical Oncology · Lewisburg Cancer Center | Evangelical Hospital
Answered on · Updated on

5-FU-induced encephalopathy is rare, involving 5.7% of patients treated with high-dose 5-FU chemotherapy. The mechanism of fluorouracil-induced encephalopathy is unclear, likely multifactorial. Two pathogenetic mechanisms have been postulated: 1. Dihydropyrimidine dehydrogenase (DPD) deficiency, in which high concentrations of 5-FU penetrate into CSF, causing acute demyelination of neurons (2.7% of the population has DPD deficiency), 2. Impairment of the ATP-dependent urea cycle resulting in tra...

Join for free or sign in to see the full answer